Nonfatal gastric mucormycosis in a renal transplant recipient.
Mucormycosis historically has caused substantial morbidity with high mortality in renal transplant patients with disseminated and/or rhinocerebral infection and in patients with gastrointestinal illness regardless of predisposing conditions. We report the first successful treatment of gastric mucormycosis in a renal transplant recipient and review presumed pathogenic mechanisms of mucormycosis in renal transplant recipients as well as historical data.
Martinez
E J
EJ
Department of Internal Medicine, University of South Florida College of Medicine, Tampa, USA.
Cancio
M R
MR
Sinnott
J T
JT
Vincent
A L
AL
Brantley
S G
SG
D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D003108:Colonic Diseases / Q000188:drug therapy / Q000382:microbiology / Q000601:surgery; D003131:Combined Modality Therapy; D005260:Female; D005743:Gastrectomy; D006801:Humans; D016030:Kidney Transplantation; D008875:Middle Aged; D009091:Mucormycosis / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery; D009894:Opportunistic Infections / Q000175:diagnosis / Q000209:etiology / Q000601:surgery; D010182:Pancreatic Diseases / Q000188:drug therapy / Q000382:microbiology / Q000601:surgery; D010538:Peritonitis / Q000188:drug therapy / Q000382:microbiology / Q000601:surgery; D012307:Risk Factors; D013272:Stomach Diseases / Q000188:drug therapy / Q000382:microbiology* / Q000601:surgery
D000935:Antifungal Agents; D000666:Amphotericin B